83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy

Sep.02.2025
83 Public Health Experts Urge European Commission: Excessive E-Cigarette Taxes Could Undermine Health Policy
Eighty-three international experts in public health and tobacco control have co-signed a letter to the European Commission warning that the forthcoming revision of the Tobacco Excise Directive could seriously harm public health if it imposes high taxes on lower-risk alternatives such as e-cigarettes, heated tobacco, and nicotine pouches. The experts argue that the EU’s stance that “non-combustible nicotine products carry risks comparable to cigarettes” contradicts scientific evidence.

Key Points

 

  • Signatories: 83 international experts in public health and tobacco control jointly sent the letter.
  • Main request: Oppose taxing e-cigarettes, heated tobacco, and nicotine pouches at levels comparable to conventional cigarettes.
  • Evidence base: Experiences in countries such as Sweden, the UK, and New Zealand show that lower-risk products can significantly reduce smoking rates and disease burden.
  • Policy risk: High excise taxes would hinder smoking cessation and switching, effectively protecting the cigarette trade and straying from evidence-based policymaking.
  • Public-health outlook: If the EU pursues a “high-tax strategy,” it may set a negative global example, especially for low- and middle-income countries.

 


 

2Firsts, September 2, 2025 — According to EUreporter, 83 international experts in public health, nicotine dependence, and tobacco control have written to the President of the European Commission and the College of Commissioners to express concerns about the EU’s upcoming revision of the Tobacco Excise Directive. They warn that imposing high taxes on lower-risk nicotine alternatives—e-cigarettes, heated tobacco products, and nicotine pouches—would stall harm-reduction progress and directly damage public health.

 

In their letter, the experts note that recent public statements by EU officials suggesting that “non-combustible nicotine products pose risks comparable to cigarettes” are at odds with existing scientific evidence and run counter to the principles of evidence-based public health policy.

 

They emphasize that smoking remains the leading cause of preventable death in the EU, causing nearly 700,000 premature deaths annually. Currently, 26% of EU adults (29% among those aged 15–24) smoke. A large body of research shows that non-combustible products—e-cigarettes, heated tobacco, and nicotine pouches—are significantly less harmful than cigarettes and have helped millions of smokers quit.

 

The experts cite international experience to support their position:

 

  • Sweden: With widespread use of snus and nicotine pouches, daily tobacco use is the lowest in the EU (<5%), and cancer incidence is 41% lower than the EU average.

 

  • United Kingdom: The government encourages smokers to switch to vaping; smoking prevalence fell from 17% to 12% over five years.

 

  • New Zealand: Daily smoking declined from 16% in 2011/12 to 7% in 2023/24, while daily vaping rose to 11% over the same period.

 

 

The letter stresses that while protecting minors is essential, this can be achieved by strictly enforcing existing restrictions on advertising and sales rather than imposing high taxes that deter adult smokers from switching to lower-risk products.

 

The authors state bluntly: “If fiscal and regulatory measures prevent smokers from moving to lower-risk alternatives, that is not only unethical; it effectively protects the cigarette trade.”

 

They conclude that EU public health is at a critical crossroads. In the coming months, the EU plans to advance both the Tobacco Products Directive (TPD) and the Tobacco Excise Directive. A “tax raid” on lower-risk products, they warn, would keep more people smoking cigarettes, harm public health, and set a negative precedent worldwide—especially for low- and middle-income countries.

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn


Notice

1.  This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2.  The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3.  This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4.  Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

 

Copyright

 

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

 

AI Assistance Disclaimer

 

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA Tobacco Center Pushes Review-Efficiency Statement After Commissioner’s Exit
FDA CTP issued a May 7 statement on accelerating product review and improving PMTA efficiency, but did not push it via official X and newsletter until May 13, one day after FDA Commissioner Marty Makary’s resignation was confirmed. FDA has not explained the delay, and no public evidence links it directly to the leadership change. The timing is notable given CTP’s usual 24-hour distribution practice.
Special Report
May.14
 FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
FDA Begins Review of 22nd Century’s VLN MRTP Renewal Applications
The U.S. Food and Drug Administration (FDA) has initiated scientific review of renewal applications for 22nd Century Group’s VLN reduced-nicotine cigarettes under the Modified Risk Tobacco Product (MRTP) pathway, with current authorizations set to expire in December 2026.
News
May.13
Thai Customs Plans Shift to Per-Unit Fines for Vapes at THB 100 Per Item
Thai Customs Plans Shift to Per-Unit Fines for Vapes at THB 100 Per Item
Thai Customs said on March 18 that it had seized more than 27.3 million foreign cigarettes and 205,445 vape products and related devices in mid-February, with a total value of more than THB 169 million.
Mar.19 by 2FIRSTS.ai
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Durbin Criticizes FDA’s First Flavored Vape Authorization, Says Trump Administration Conceded to Big Tobacco
U.S. Senator Dick Durbin on May 13 criticized the Trump Administration’s Food and Drug Administration for approving the sale and marketing of fruit-flavored e-cigarettes for the first time, while also allowing some illegal vaping products to remain on the market. He also linked the regulatory shift to the departure of FDA Commissioner Marty Makary, saying White House pressure on regulators to approve tobacco product applications could create serious public-health consequences.
Regulations
May.15
Philippine Anti-Smoking Groups Urge DTI Action Over Alleged Vape Law Violations by ZYN and IQOS
Philippine Anti-Smoking Groups Urge DTI Action Over Alleged Vape Law Violations by ZYN and IQOS
Several anti-smoking and health advocacy groups in the Philippines urged the Department of Trade and Industry to take action against tobacco companies accused of violating the Vape Regulation Act of 2022. The groups said three consecutive complaints had been filed involving nicotine pouch brand ZYN and heated tobacco product company IQOS Philippines.
Apr.27 by 2FIRSTS.ai
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
ITC Keeps Exclusion and Cease-and-Desist Orders in Place Against Stiiizy
U.S. International Trade Commission has refused to pause the import and sales bans imposed on cannabis vape company Stiiizy while it appeals the agency’s patent infringement ruling in its dispute with Pax Labs.
Apr.07 by 2FIRSTS.ai